E-LIB Suche - Ergebnisse für: Kerstin Maas Enriquez

1

Modeling Drosophila gut microbe interactions reveals metabo..:

Schönborn, Jürgen W. ; Stewart, Fiona A. ; Enriquez, Kerstin Maas...
iScience. 24 (2021) 11 - p. 103216 , 2021

2

Modeling Drosophila gut microbe interactions reveals metabo..:

Jürgen W. Schönborn ; Fiona A. Stewart ; Kerstin Maas Enriquez...
http://www.sciencedirect.com/science/article/pii/S2589004221011846. , 2021

Link: https://doi.org/10.1016/..

3

Control of Drosophila Growth and Survival by the Lipid Drop..:

Werthebach, Michael ; Stewart, Fiona A. ; Gahlen, Alisa...
Cell Reports. 26 (2019) 13 - p. 3726-3740.e7 , 2019

Link: https://doi.org/10.1016/..

4

Control of Drosophila Growth and Survival by the Lipid Drop..:

Michael Werthebach ; Fiona A. Stewart ; Alisa Gahlen...
http://www.sciencedirect.com/science/article/pii/S2211124719302967. , 2019

Link: https://doi.org/10.1016/..

5

Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prop..:

Reding, Mark T. ; Simpson, Mindy ; Ducore, Jonathan...
Acta Haematologica. , 2024

Link: https://doi.org/10.1159/..

6

Safety and efficacy of damoctocog alfa pegol prophylaxis in..:

Holme, Pål André ; Poulsen, Lone Hvitfeldt ; Tueckmantel, Claudia...
Haemophilia. 30 (2024) 2 - p. 388-394 , 2024

Link: https://doi.org/10.1111/..

7

A post hoc analysis of PROTECT VIII kids assessing long‐ter..:

Ahuja, Sanjay ; Biss, Tina ; Maas Enriquez, Monika...
European Journal of Haematology. 112 (2024) 5 - p. 756-764 , 2024

Link: https://doi.org/10.1111/..

8

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T. ; Pabinger, Ingrid ; Holme, Pål Andrè...
Therapeutic Advances in Hematology. 14 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

9

Confirmed long‐term safety and efficacy of prophylactic tre..:

Reding, Mark T. ; Pabinger, Ingrid ; Holme, Pal Andre...
Haemophilia. 27 (2021) 3 - p. , 2021

Link: https://doi.org/10.1111/..

10

BAY 94‐9027 prophylaxis is efficacious and well tolerated f..:

Lalezari, Shadan ; Reding, Mark T. ; Pabinger, Ingrid...
Haemophilia. 25 (2019) 6 - p. 1011-1019 , 2019

Link: https://doi.org/10.1111/..

11

Matching-adjusted indirect comparisons of efficacy of BAY 8..:

Li, Nanxin ; Pocoski, Jennifer ; Ayyagari, Rajeev...
Journal of Blood Medicine. 7 (2016) - p. 129-137 , 2016

Link: https://doi.org/10.2147/..

12

Chromogenic assay for BAY 81‐8973 potency assignment has no..:

Kitchen, S. ; Katterle, Y. ; Beckmann, H..
Journal of Thrombosis and Haemostasis. 14 (2016) 6 - p. 1192-1199 , 2016

Link: https://doi.org/10.1111/..

13

BAY 81-8973, a full-length recombinant factor VIII: Human h..:

Maas Enriquez, Monika ; Thrift, John ; Garger, Stephen.
Protein Expression and Purification. 127 (2016) - p. 111-115 , 2016

Link: https://doi.org/10.1016/..

14

Efficacy and safety of BAY 81‐8973, a full‐length recombina..:

Saxena, K. ; Lalezari, S. ; Oldenburg, J....
Haemophilia. 22 (2016) 5 - p. 706-712 , 2016

Link: https://doi.org/10.1111/..

15

BAY 81‐8973, a full‐length recombinant factor VIII: results..:

Kitchen, S. ; Beckmann, H. ; Katterle, Y....
Haemophilia. 22 (2016) 3 - p. , 2016

Link: https://doi.org/10.1111/..